Clinical Trial Update: Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating dynamic contrast-enhanced MRI to assess tumor-associated vasculature in patients with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Breast Neoplasms | Status: COMPLETED